Efficacy of Synbiotics to Reduce Symptoms and Rectal Inflammatory Response in Acute Radiation Proctitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

References

• Paydar I, Cyr RA, Yung TM, Lei S, Collins BT, et al.: Proctitis 1 week after stereotactic body radiation therapy for prostate cancer: Implications for clinical trial design. Front Oncol 6, 167, 2016.
   PubMed Web of Science ®Google Scholar
• Do NL, Nagle D, and Poylin VY: Radiation proctitis: Current strategies in management. Gastroenterol Res Pract 2011, 1–941, 2011.
   Web of Science ®Google Scholar
• Arunsingh M, Mallick I, Prasath S, Arun B, Sarkar S, et al.: Acute toxicity and its dosimetric correlates for high-risk prostate cancer treated with moderately hypofractionated radiotherapy. Med Dosim 42, 18–23, 2017.
   PubMed Web of Science ®Google Scholar
• Lips IM, Dehnad H, van Gils CH, Kruger AEB, van der Heide UA, and van Vulpen M: High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: Acute and late toxicity in 331 patients. Radiat Oncol 3, 15, 2008.
   PubMed Web of Science ®Google Scholar
• De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, et al.: Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 60, 777–787, 2004.
   PubMed Web of Science ®Google Scholar
• Lesperance RN, Kjorstadt RJ, Halligan JB, and Steele SR: Colorectal complications of external beam radiation versus brachytherapy for prostate cancer. Am J Surg 195, 616–620, 2008.
   PubMed Web of Science ®Google Scholar
• Wedlake L, McGough C, Hackett C, Thomas K, Blake P, et al.: Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa? Aliment Pharmacol Ther 27, 980–987, 2008.
   PubMed Web of Science ®Google Scholar
• Hovdenak N, Fajardo LF, and Hauer-Jensen M: Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 48, 1111–1117, 2000.
   PubMed Web of Science ®Google Scholar
• Larsen A, Hovdenak N, Karlsdottir A, Wentzel‐Larsen T, Dahl O, and Fagerhol MK: Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. Scand J Gastroenterol Suppl 39, 1113–1118, 2004.
   Google Scholar
• Garg AK, Mai WY, McGary JE, Grant WH, 3rd, Butler EB, and Teh BS: Radiation proctopathy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 66, 1294–1305, 2006.
   PubMed Web of Science ®Google Scholar
• Lenz L, Rohr R, Nakao F, Libera E, and Ferrari A: Chronic radiation proctopathy: A practical review of endoscopic treatment. Wjgs 8, 151–160, 2016.
   Web of Science ®Google Scholar
• Krol R, Smeenk RJ, van Lin EN, Yeoh EE, and Hopman WP: Systematic review: Anal and rectal changes after radiotherapy for prostate cancer. Int J Colorectal Dis 29, 273–283, 2014.
   PubMed Web of Science ®Google Scholar
• Vanneste BG, Van De Voorde L, de Ridder RJ, Van Limbergen EJ, Lambin P, and van Lin EN: Chronic radiation proctitis: Tricks to prevent and treat. Int J Colorectal Dis 30, 1293–1303, 2015.
   PubMed Web of Science ®Google Scholar
• Goldner G, Tomicek B, Becker G, Geinitz H, Wachter S, et al.: Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: Results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys 67, 78–83, 2007.
   PubMed Web of Science ®Google Scholar
• Yeoh EK, Holloway RH, Fraser RJ, Botten RJ, Di Matteo AC, and Butters J: Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 84, e593–9, 2012.
   PubMed Web of Science ®Google Scholar
• Gami B, Harrington K, Blake P, Dearnaley D, Tait D, et al.: How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 18, 987–994, 2003.
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DMK, Lalla RV, Bateman E, Blijlevens N, et al.: Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21, 313–326, 2013.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, et al.: Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514, 2014.
   PubMed Web of Science ®Google Scholar
• Delia P, Sansotta G, Donato V, Frosina P, Messina G, et al.: Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 13, 912–915, 2007.
   PubMed Web of Science ®Google Scholar
• Giralt J, Regadera JP, Verges R, Romero J, de la Fuente I, et al.: Effects of probiotic Lactobacillus casei DN-114001 in prevention of radiation-induced diarrhea: Results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 71, 1213–1219, 2008.
   PubMed Web of Science ®Google Scholar
• Castro MG, Sanchez PX, Glasberg J, Horie LM, Waitzberg DL, et al.: Effects of probiotic in prevention of radiation-induced diarrhea. Clin Nutr Suppl 4, 72–73, 2009.
   Google Scholar
• Chitapanarux I, Chitapanarux T, Taisathit P, et al.: Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol May 5, 5–31, 2010.
   PubMed Web of Science ®Google Scholar
• Demers M, Dagnault A, and Desjardins J: A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 33, 761–767, 2014.
   PubMed Web of Science ®Google Scholar
• Hamad A, Fragkos KC, and Forbes A: A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr 32, 353–360, 2013.
   PubMed Web of Science ®Google Scholar
• Liu MM, Li ST, Shu Y, and Zhan HQ: Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials. PLoS One 12, e0178870, 2017.
   PubMed Web of Science ®Google Scholar
• Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, et al.: Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12, 1044–1052, 2006.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, et al.: Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293, G729–G738, 2007.
   PubMed Web of Science ®Google Scholar
• Musenga A, Mandrioli R, Bonifazi P, Kenndler E, Pompei A, et al.: Sensitive and selective determination of glutathione in probiotic bacteria by capillary electrophoresis-laser induced fluorescence. Anal Bioanal Chem 387, 917–924, 2007.
   PubMed Web of Science ®Google Scholar
• Kodali VP, and Sen R: Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol J 3, 245–251, 2008.
   PubMedGoogle Scholar
• Cummings JH, Pomare EW, Branch WJ, Naylor CP, and Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227, 1987.
   PubMed Web of Science ®Google Scholar
• Vogt SL, Pena-Diaz J, and Finlay BB: Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34, 106–115, 2015.
   PubMed Web of Science ®Google Scholar
• Pryde SE, Duncan SH, Hold GL, Stewart CS, and Flint HJ: The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133–139, 2002.
   PubMed Web of Science ®Google Scholar
• Peng L, Li ZR, Green RS, Holzman IR, and Lin J: Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139, 1619–1625, 2009.
   PubMed Web of Science ®Google Scholar
• Gill PA, van Zelm MC, Muir JG, and Gibson PR: Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther 48, 15–34, 2018.
   PubMed Web of Science ®Google Scholar
• Maggio A, Magli A, Rancati T, Fiorino C, Valvo F, et al.: Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study. Int J Radiat Oncol Biol Phys 89, 518–524, 2014.
   PubMed Web of Science ®Google Scholar
• Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, et al.: Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14, 491–502, 2017.
   PubMed Web of Science ®Google Scholar
• Tsitko I, Wiik-Miettinen F, Mattila O, Rosa-Sibakov N, Seppänen-Laakso T, et al.: A small in vitro fermentation model for screening the gut microbiota effects of different fiber preparations. Int J Mol Sci 20, 1925, 2019.
   PubMed Web of Science ®Google Scholar
• Garcia-Peris P, Velasco C, Hernandez M, Lozano MA, Paron L, et al.: Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: A randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 70, 170–174, 2016.
   PubMed Web of Science ®Google Scholar
• Schrezenmeir J, and de Vrese M: Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 73, 361S–364S, 2001.
   PubMed Web of Science ®Google Scholar
• Nascimento M, Aguilar-Nascimento JE, Caporossi C, Castro-Barcellos HM, and Motta RT: Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial. Int J Radiat Oncol Biol Phys 90, 289–295, 2014.
   PubMed Web of Science ®Google Scholar
• Spry N, Halkett G, Aoun S, Spry J, Yeoh E, et al.: Development of a European Organization for Research and Treatment of Cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy. Int J Rad Oncol Biol Phys 72, 522–528, 2008.
   PubMed Web of Science ®Google Scholar
• Halkett G, Aoun S, Hayne D, Lund J-A, Gruen A, et al.: EORTC radiation proctitis-specific quality of life module - pretesting in four European countries . Radiother Oncol 97, 294–300, 2010.
   PubMed Web of Science ®Google Scholar
• European Organisation for Research and Treatment of Cancer. EORTC Quality of Life Groups – Translation Procedure [internet]. Bruxelas, 2009. [Accessed on November 2, 2011]. http://groups.eortc.be/qol/sites/default/files/archives/translation_manual_2009.pdf
   Google Scholar
• Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, EORTC Quality of Life Group, et al.: Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 43, 1810–1820, 2007.
   PubMed Web of Science ®Google Scholar
• Hille A, Schmidt-Giese E, Hermann RM, Herrmann MKA, Rave-Fränk M, et al.: A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment. Scand J Gastroenterol 43, 52–58, 2008.
   PubMed Web of Science ®Google Scholar
• BÜHLMANN Laboratories AG, Baselstrasse 55, CH-4124, Schönenbuch/Basel Switzerland. https://www.buhlmannlabs.ch/products-solutions/gastroenterology/calprotectin/
   Google Scholar
• Guo S, He X, Chen Q, Yang G, Yao K, et al.: The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients. BMC Cancer 17, 171, 2017.
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Serafini F, et al.: Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. Int J Radiat Oncol Biol Phys 78, 26–34, 2010.
   PubMed Web of Science ®Google Scholar
• Barnett GC, De Meerleer G, Gulliford SL, Sydes MR, Elliott RM, et al.: The impact of clinical factors on the development of late radiation toxicity: Results from the Medical Research Council RT01 trial (ISRCTN47772397). Clin Oncol (R Coll Radiol) 23, 613–624, 2011.
   PubMed Web of Science ®Google Scholar
• Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, et al.: The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys 76, 342–348, 2010.
   PubMed Web of Science ®Google Scholar
• Margel D, Baniel J, Wasserberg N, Bar-Chana M, and Yossepowitch O: Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer. Ann Surg 254, 947–950, 2011.
   PubMed Web of Science ®Google Scholar
• Davis EJ, Beebe-Dimmer JL, Yee CL, and Cooney KA: Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study. Cancer 120, 2735–2741, 2014.
   PubMed Web of Science ®Google Scholar
• Rombouts AJM, Hugen N, van Beek JJP, Poortmans PMP, de Wilt JHW, and Nagtegaal ID: Does pelvic radiation increase rectal cancer incidence? – A systematic review and meta-analysis. Cancer Treat Rev 68, 136–144, 2018.
   PubMed Web of Science ®Google Scholar